The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose
Clinical trial NCT04977479 · COMPLETED
Trial details
- NCT number
- NCT04977479
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-08
- Primary completion
- 2022-06-17
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.